This inventor holds 10 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignees: Bausch Health Ireland Limited, Synergy Pharmaceuticals, Inc., Bestway Inflatables & Material Corp.. Active years: 2017-2026.
Company Filing History:
6 out of 45 
2 out of 34 
1 out of 131 Years Active: 2017-2026
Title: Qiao Zhao: Innovator in Guanylate Cyclase C Agonists
Introduction
Qiao Zhao is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of biochemistry, particularly in the development of ultra-pure agonists of guanylate cyclase C. With a total of nine patents to her name, her work has the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Among her latest patents is the invention titled "Ultra-pure agonists of guanylate cyclase C, method of making and using same." This invention provides processes for purifying a peptide that includes a guanylate cyclase C agonist sequence. The processes involve a solvent exchange step prior to a freeze-drying (lyophilization) step. This innovative approach enhances the purity and efficacy of the agonists, which could lead to improved therapeutic outcomes.
Career Highlights
Qiao Zhao has worked with notable companies in the pharmaceutical industry, including Bausch Health Ireland Limited and Synergy Pharmaceuticals, Inc. Her experience in these organizations has allowed her to refine her expertise in drug development and peptide purification.
Collaborations
Throughout her career, Qiao has collaborated with esteemed colleagues such as Kunwar Shailubhai and Stephen Comiskey. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Qiao Zhao's contributions to the field of biochemistry through her patents and collaborations highlight her role as a leading inventor. Her work on guanylate cyclase C agonists showcases the potential for advancements in medical therapies.